Exane Derivatives Cerence Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Cerence Inc. stock. As of the latest transaction made, Exane Derivatives holds 31 shares of CRNC stock, worth $425. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31
Previous 1,550
98.0%
Holding current value
$425
Previous $55,000
100.0%
% of portfolio
0.0%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding CRNC
# of Institutions
198Shares Held
33.2MCall Options Held
1MPut Options Held
887K-
American Capital Management Inc New York, NY3.49MShares$47.9 Million1.02% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$45.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.16MShares$43.4 Million0.0% of portfolio
-
Cooper Creek Partners Management LLC New York, NY1.95MShares$26.8 Million0.47% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.86MShares$25.6 Million0.01% of portfolio
About Cerence Inc.
- Ticker CRNC
- Exchange NASDAQ
- Sector Technology
- Industry Software—Application
- Shares Outstandng 39,313,000
- Market Cap $540M
- Description
- Cerence Inc. provides AI powered virtual assistants for the mobility/transportation market worldwide. The company offers edge software components; cloud-connected components and related toolkits and applications; and virtual assistant coexistence and professional services. It also provides conversational artificial intelligence-based solutions, ...